http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0639072-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_153bfbead8dc42f3487485076fb7ea77
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
filingDate 1993-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4627511eb4248355e62a992f930af37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_643de0577bea49d31d2129e317d96551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a4712df644622cd1b3798f9c31d1ce3
publicationDate 1998-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0639072-B1
titleOfInvention Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration
abstract PCT No. PCT/EP93/01077 Sec. 371 Date Dec. 29, 1994 Sec. 102(e) Date Dec. 29, 1994 PCT Filed May 3, 1993 PCT Pub. No. WO93/21916 PCT Pub. Date Nov. 11, 1993The present invention relates to a pharmaceutical composition for rectal administration in solid dosage form which comprises a compound acting as a 5HT-1 like receptor agonist in the form of its free base or a physiologically acceptable hard fat base carrier having a hydroxyl value of more than 15 in the method for the treament of a mammal suffering from a susceptible to conditions associated with cephalic pain.
priorityDate 1992-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394190
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67578549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233929564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57476618
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227181611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67614860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395574
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234029098
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226449465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19711219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127427940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234031472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9926171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56605938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227996838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59772

Total number of triples: 53.